Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Mouse PDCs were specifically depleted in BALB/c mice by i.p. injection of 500 µg CD317 (PDCA-1) pure – functional grade. The frequency of CD317 (PDCA-1) + PDCs was analyzed in spleen 24 hours after injection of the antibody or diluent only (control mice) by staining with CD317 (PDCA-1) antibodies. To exclude blocking of CD317 (PDCA-1) staining by the in vivo applied CD317 (PDCA-1) antibody, cells were additionally stained with Anti-Ly-6C and CD45R (B220) antibodies. Note that the frequency of PDCs decreases in mice which received the CD317 (PDCA-1) antibody (A) to about one fifth compared to control mice (B), independent of whether it is analyzed based on CD317 (PDCA-1) staining or on Anti-Ly-6C and CD45R (B220) staining. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. |
A) Anti-mPDCA-1 antibody |
B) Control |
Copyright © 2019 Miltenyi Biotec and/or its affiliates. All rights reserved.